全文获取类型
收费全文 | 9854篇 |
免费 | 1596篇 |
国内免费 | 154篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 286篇 |
妇产科学 | 61篇 |
基础医学 | 642篇 |
口腔科学 | 249篇 |
临床医学 | 1942篇 |
内科学 | 1791篇 |
皮肤病学 | 84篇 |
神经病学 | 713篇 |
特种医学 | 69篇 |
外科学 | 555篇 |
综合类 | 791篇 |
现状与发展 | 1篇 |
预防医学 | 849篇 |
眼科学 | 112篇 |
药学 | 2369篇 |
15篇 | |
中国医学 | 755篇 |
肿瘤学 | 288篇 |
出版年
2024年 | 46篇 |
2023年 | 336篇 |
2022年 | 375篇 |
2021年 | 698篇 |
2020年 | 741篇 |
2019年 | 708篇 |
2018年 | 660篇 |
2017年 | 587篇 |
2016年 | 525篇 |
2015年 | 540篇 |
2014年 | 850篇 |
2013年 | 1050篇 |
2012年 | 565篇 |
2011年 | 586篇 |
2010年 | 435篇 |
2009年 | 426篇 |
2008年 | 358篇 |
2007年 | 325篇 |
2006年 | 293篇 |
2005年 | 239篇 |
2004年 | 165篇 |
2003年 | 155篇 |
2002年 | 143篇 |
2001年 | 137篇 |
2000年 | 108篇 |
1999年 | 59篇 |
1998年 | 59篇 |
1997年 | 47篇 |
1996年 | 47篇 |
1995年 | 36篇 |
1994年 | 35篇 |
1993年 | 36篇 |
1992年 | 33篇 |
1991年 | 23篇 |
1990年 | 24篇 |
1989年 | 18篇 |
1988年 | 16篇 |
1987年 | 20篇 |
1986年 | 12篇 |
1985年 | 16篇 |
1984年 | 15篇 |
1983年 | 12篇 |
1982年 | 9篇 |
1981年 | 14篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1971年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
彭卫东 刘刚 葛宇峰 谭哲伦 陈依民 高峰 张京 张馨艺 何久盛 文良元 王现海 史宗新 胡三保 孙凤坡 龚子顺 孙明曜 田懋一 朱仕文 杨明辉 吴新宝 《中华解剖与临床杂志》2023,28(1):1-6
目的 评估北京地区老年髋部脆性骨折患者术后抗骨质疏松症药物(AOM)治疗现状并探讨其影响因素。方法 横断面研究。纳入2018年11月—2019年11月北京积水潭医院、北京医院、北京安贞医院、北京市昌平区医院、北京市顺义区医院、北京市房山区良乡医院收治的髋部脆性骨折患者1 963例,总结其人口学特征,并收集患者入院后30、120、365 d的临床资料,AOM治疗及健康基本补充剂使用情况。通过单因素和多因素logistic回归分析AOM治疗的影响因素。结果 1 963例老年髋部脆性骨折患者,住院时年龄65~102(79.3±7.2)岁,≥80岁患者占56.7%(1 113/1 963);男性患者占30.8%(604/1 963),女性患者占69.2%(1 359/1 963);股骨颈骨折846例,股骨粗隆间骨折1 077例,股骨粗隆下骨折40例。综合3个时间点,在髋部骨折后1年内,33.0%(648/1 963)的患者接受过AOM治疗,71.0%(1 394/1 963)的患者使用过健康基本补充剂。入院后30、120、365 d患者AOM治疗率分别为23.0%(451/1 963)、17.9%(353/1 963)、21.0%(412/1 963),健康基本补充剂使用率分别为59.0%(1 158/1 963)、45.0%(883/1 963)、38.0%(746/1 963)。单因素分析结果显示,年龄≥80岁[粗比值比(OR)=0.645,95%可信区间(CI) 0.495~0.840]、男性(粗OR=0.760,95% CI 0.581~0.996)、共管模式(粗OR=3.025,95% CI 0.973~9.405)、居住地农村(粗OR=0.523,95% CI 0.388~0.704)、AOM服用史(粗OR=7.612,95% CI 2.227~26.020)、既往骨质疏松症史(粗OR=5.065,95% CI 3.149~8.147)、骨质疏松评估(粗OR=1.379,95% CI 1.105~2.451)是AOM治疗的影响因素。多因素分析结果显示,年龄≥80岁(调整后OR=0.618,95% CI 0.488~0.781)、男性(调整后OR=0.716,95% CI 0.565~0.908)、居住地农村(调整后OR=0.492,95% CI 0.375~0.645)是AOM治疗的危险因素;共管模式(调整后OR=2.632,95% CI 1.004~6.897)、AOM服用史(调整后OR=4.870,95% CI 2.080~11.402)、既往骨质疏松症史(调整后OR=4.804,95% CI 3.253~7.096)、骨质疏松评估(调整后OR=1.393,95% CI 1.041~1.862)是AOM治疗的保护因素。结论 北京地区老年髋部脆性骨折患者的AOM治疗率偏低。年龄≥80岁、男性、在农村居住的髋部脆性骨折患者治疗率较低,可采取共管模式,术前进行骨质疏松诊断与评估,提高骨质疏松治疗率。 相似文献
82.
Sarah Duncan-Park Claire Dunphy Jacqueline Becker Christine D’Urso Rachel Annunziato Joshua Blatter Carol Conrad Samuel B. Goldfarb Don Hayes Jr. Ernestina Melicoff Marc Schecter Gary Visner Brian Armstrong Hyunsook Chin Karen Kesler Nikki M. Williams Jonah N. Odim Stuart C. Sweet Lara Danziger-Isakov Eyal Shemesh 《American journal of transplantation》2021,21(9):3112-3122
Remote interventions are increasingly used in transplant medicine but have rarely been rigorously evaluated. We investigated a remote intervention targeting immunosuppressant management in pediatric lung transplant recipients. Patients were recruited from a larger multisite trial if they had a Medication Level Variability Index (MLVI) ≥2.0, indicating worrisome tacrolimus level fluctuation. The manualized intervention included three weekly phone calls and regular follow-up calls. A comparison group included patients who met enrollment criteria after the subprotocol ended. Outcomes were defined before the intent-to-treat analysis. Feasibility was defined as ≥50% of participants completing the weekly calls. MLVI was compared pre- and 180 days postenrollment and between intervention and comparison groups. Of 18 eligible patients, 15 enrolled. Seven additional patients served as the comparison. Seventy-five percent of participants completed ≥3 weekly calls; average time on protocol was 257.7 days. Average intervention group MLVI was significantly lower (indicating improved blood level stability) at 180 days postenrollment (2.9 ± 1.29) compared with pre-enrollment (4.6 ± 2.10), p = .02. At 180 days, MLVI decreased by 1.6 points in the intervention group but increased by 0.6 in the comparison group (p = .054). Participants successfully engaged in a long-term remote intervention, and their medication blood levels stabilized. NCT02266888. 相似文献
83.
Pablo Martinez-Perez Domingo Orozco-Beltrán Francisco Pomares-Gomez Juan L. Hernández-Rizo Anna Borras-Gallen Vicente F. Gil-Guillen Jose A. Quesada Adriana Lopez-Pineda Concepción Carratala-Munuera 《Atencion primaria / Sociedad Espa?ola de Medicina de Familia y Comunitaria》2021,53(2):101942
AimsTo validate a translated and culturally adapted version of the Morisky Medication Adherence Scale for use in Spanish population, and to examine the psychometric properties of this scale in patients with type 2 diabetes mellitus in Spain.DesignThis cross-sectional study was conducted in a single university hospital in Spain. Patients diagnosed with type 2 diabetes mellitus at least 1 year before inclusion, being treated with anti-diabetic medication were included.InterventionWe used the Spanish version of the scale to measure treatment adherence.Principal measurementsthree level categorical scale is broken down into low adherence (score of <6), medium adherence (score of 6 to <8) and high adherence (score of 8). To validate the questionnaire, we measured internal consistency through Cronbach's α, confirmed construct validity through an exploratory principal component analysis and assessed test–retest reliability.Results232 patients met the inclusion criteria. The Cronbach's α coefficient was 0.40 (95% CI 0.28–0.52). The exploratory principal component analysis showed three components. The intraclass correlation coefficient was 0.718 (95% CI 0.564–0.823).Conclusionsthe Spanish version of the Morisky Medication Adherence scale showed low internal consistency, the exploratory factor analysis identified three dimensions, and the test–retest reliability was acceptable, therefore, psychometric properties of MMAS-8 are not suitable for measuring medication adherence in type 2 diabetes mellitus patients from Spain. 相似文献
84.
Yosi Wibowo Ph.D Adji P. Setiadi Dr. Steven V. Halim M.Pharm. Rama D. Saputra B.Pharm. Rizka Oktavia B. Pharm. Rizky Irianti B. Pharm. Putri I. Lestari B. Pharm Cecilia R. Puspitasari B.Pharm. Bruce Sunderland Ph.D. 《Health & social care in the community》2021,29(2):554-563
In 2015, the Indonesian Government initiated ‘Smart Use of Medications Movement’ (‘GeMa CerMat’) which included cadre training to promote responsible self-medication. Evaluation of a pilot training conducted across Indonesia suggested the need to improve those training modules. This study aimed to assess cadre’ knowledge gained following training with newly developed general or specific training modules. Five types of modules were developed and used to train cadres at five Community Health Centres (CHCs) in Surabaya, Indonesia: 1) Sidosermo CHC (general-drugs module), 2) Tenggilis CHC (common cold drugs module), 3) Gunung Anyar CHC (analgesic drugs module), 4) Kalirungkut CHC (anti-diarrhoeal drugs module), and 5) Jagir CHC (indigestion drugs module). Cadres’ knowledge improvements were evaluated using pre-/post-test scores and the difference scores depending on the module being tested. Multifactorial ANOVA explored the effects of the type of module on difference scores. A total of 279 cadres across five CHCs were involved in the training, giving response rates from 65% to 93%. There was an increase in the post-test scores after the training with all modules. However, significant differences were reported only for the specific-drugs module groups (all p < .001). Furthermore, the general module group had the lowest difference score (1.12; 95% CI [−0.45, 2.92]) while the common cold module group had the highest gain (5.02; 95% CI [1.95, 5.17]). Multifactorial ANOVA revealed that there was a significant main effect of the type of modules on difference scores [F (4, 263) = 8.37, p <.001]. In conclusion, this preliminary study indicated that the development of modules for specific minor illnesses could be beneficial in facilitating effective community-based training to promote responsible self-medication in Indonesia. The priority for therapeutic areas chosen for the module should be based on the local needs. Further research is required to confirm the findings in broader community members. 相似文献
85.
Issues in adherence with pediatric regimens 总被引:1,自引:3,他引:1
A M La Greca 《Journal of pediatric psychology》1990,15(4):423-436
Adherence to recommendations for health care is an area of serious concern for pediatric psychologists. The present article highlights several key issues affecting research and clinical work in this area. They include: difficulties defining and measuring adherence; developmental aspects of adherence; special concerns with low income populations; and limitations of intervention research. In addition, several directions for future investigation in the area of pediatric adherence are addressed. 相似文献
86.
Modified sternal elevation for children with pectus excavatum 总被引:2,自引:0,他引:2
Objective To investigate the relationship between intestinal mucus IgA content and mucus barrier function after surface burns. Methods Detection of IgA content in mucus was performed by enzyme linked immunosorbent assay (ELISA) at different time points after burns.Bacterial adherence to cultured epithelial cells (IEC-6) in vitro using E.coli was assessed for each group. Results The intestinal mucus barrier function declined, parallel to a decrease in IgA content after surface burn in mice.In the normal control group, mucus IgA content was 2.32 Dλ, and 2.51, 1.76, 1.49, 1.06 Dλ at 0.5 h, 1 h, 6 h and 24 h after burn, respectively.Bacterial adherence rate was 0.53 in control group, and 0.46, 0.69, 0.58, 0.81 at 0.5 h, 1 h, 6 h, 24 h after burn, respectively. Conclusion The decrease of intestinal mucus IgA contents is one of the reasons why intestinal mucus barrier function declines after burns. 相似文献
87.
目的 观察羟基喜树碱(HCPT)和5-氟脲嘧啶(5-Fu)联合化疗治疗晚期胃肠道肿瘤的近期疗效和毒副反应。方法HCPT10mg/d,静脉点滴,连用10天;5-Fu0.75mg/d,静脉点滴年,连用5天。21天为-个周期,二至三个周期观察疗效。结果20例胃癌CR1例,PR9例,NC6例,PD4例,总有效率(CR PR)为50%;结肠癌15例中CR2例,PR6例,NC5例,PD2例,(CR PR)为53.3%。毒副反应多为胃肠道反应及骨髓毒性,多为1~2级。结论以HCPT和5-Fu联合治疗晚期胃肠道肿瘤疗效较好,且毒副反应可以耐受。 相似文献
88.
INTRODUCTION Enteropathogenic E.coli (EPEC) is one of theimportant pathogens for infant diarrhoae and urinarytract infections in adults.The chemotherapy andchemoprophylaxis of EPEC infections by antibiotics arechallenged by the development of multi- resistant strainsand the colonization of pathogenic bacteria in vivo as aresult of gutflora dysfunction.Since late1980 s’,ithasbeen found that the infection of mammalian cells byEPEC occured in two steps:adhesion of bacteria to cells… 相似文献
89.
HFJV联合药物治疗兔海水淹溺肺水肿 总被引:2,自引:0,他引:2
目的:观察高频喷射通气(HFJV)联合4种药物治疗海水淹溺肺水肿(PE-SWD)的效果并探讨其作用机制。方法:用海水灌注的方法诱导PE-SWD模型,采用HFJV联合地塞米松、东莨菪碱、尼莫地平和果糖二磷酸钠4种药物进行治疗,观察记录相关的生理、生化指标。结果:HFJV联合4种药物治疗能明显改善PE-SWD相关指标。结论:HFJV联合4种药物治疗能有效治疗PE-SWD,可作为其基础治疗。 相似文献
90.
The number of child psychiatrists, paediatricians and general practitioners prescribing psychotropic medication for children in the UK is increasing. Medication is being used not just to treat children of normal intelligence with hyperkinetic disorder or depression, but also to modify behavioural problems in children with developmental disorders and severe learning difficulties. Literature reviews highlight the lack of robust randomized controlled drug trials on which to base clinical practice and the authors have found no appropriate existing protocols to help develop a systematized approach. Against such a background the authors have developed a comprehensive set of protocols covering prescribing details for individual drugs, and also addressing issues such as informed consent, long-term monitoring and school liaison. All children referred to the authors' clinics go through a standardized decision-making process. This article describes both the protocols themselves and the philosophies that guided their development. The authors describe how such a system benefits the children, their families, general practitioners and schools, whilst also facilitating audit and research. 相似文献